Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether the drug uproleselan can help patients with
severe COVID-19 pneumonia. Investigators will study both the side effects of the drug and
assess if the drug will help patients recover more quickly and slow down the progression of
acute respiratory failure.